The Artificial Cervical Disc Market Size was valued at USD 1.75 billion in 2023 and is expected to reach USD 2.23 billion by 2031, and grow at a CAGR of 3.1% over the forecast period 2024-2031.
The dynamics are expected to be positively affected by increasing incidences of degenerative disc disease in the world. According to Medicare, the rate of prevalence of spine degeneration is more than 25% in the U.S., with a higher incidence rate in women as compared to men. The growing elderly population, driven by musculoskeletal ageing, represents a large patient population with unmet medical needs related to back pain. The costs of these products are increased by the increasing sophistication of the technologies used in medical devices and implants. For example, cervical total disc replacement CTDR implant costs between USD 9,000 and USD 12,000. However, the scope of this industry will be enhanced by developments in CTDR devices for treating cervical diseases and appropriate training to surgeons regarding proper handling of medical equipment.
Get more information on Artificial Cervical Disc Market - Request Sample Report
MARKET DYNAMICS
DRIVERS
Increased incidence of degenerative spine diseases worldwide
The ageing of the population in both developed and developing countries' economies
Increased Awareness among People
The existence and benefits of Artificial Cervical Discs are becoming more widely known to patients and healthcare providers. More and more people are recognizing the potential benefits of these instruments to treat Cervical spine disorders, as awareness increases. The expansion of the artificial cervical disc market has been driven by this increased awareness and recognition. The demand for and use of the Artificial Cervical Discs is increasing, giving rise to a greater market presence and growth potential as more people and healthcare professionals take advantage of this innovation.
RESTRAINTS
The price of the product is high
Inconsistent reimbursement procedures
The lack of consistency and coherence in the policies and criteria determining how healthcare providers will be paid for services or treatments. Differences in the guidelines, coverage decisions and payment rates of various healthcare systems, insurance companies or public programmes can lead to this inconsistency. Providers may find it difficult to receive equitable compensation for the services they provide, while patients might face unequal access to some treatments or interventions on the basis of reimbursement policies currently in place. In order to ensure a fair and efficient delivery of healthcare, this issue highlights the need for transparency and standardised payment procedures.
OPPORTUNITIES
Additional clinical trials with artificial discs will be carried out
In particular within the medical and scientific community, there is growing interest in conducting research and studies involving artificial discs. These tests are intended to assess the effectiveness, safety and potential benefits of artificial discs in a variety of medical applications such as spinal surgery. Commitment to further investigating the performance and outcomes of disc implants, which could ultimately result in advances in medicine and better care for patients, has contributed to an increase in laboratory tests.
CHALLENGES
A major challenge for market participants is the risk associated with surgery and medical procedures
Russia-Ukraine conflict may interrupt supply chains may be interrupted by the Russia Ukraine conflict, resulting in shortages of components for artificial cervical discs, and patient demand for artificial cervical disc surgery may be reduced. Regulatory delays may be a barrier to the introduction of fresh products. Medical supply prices may increase due to the dependency of healthcare organisations on common resources. Investment in R&D may decrease as a result of geopolitical uncertainty. Global market volatility could have an impact on investor confidence and healthcare spending related to artificial cervical disc procedures. The capacity for early artificial cervical disc procedures may be limited by the burden on healthcare infrastructure. Public awareness and education on ACDs may weaken in times of crisis. The artificial cervical disc market may be affected by permanent changes in healthcare policy and funding priorities as a result of the conflict.
Economic downturns are often accompanied by reduced healthcare spending and consumer uncertainty, which can have a significant impact on the artificial cervical disc market if they result in declining elective surgery such as recession. The economic downturn often results in reduced health spending and consumer uncertainty, which can lead to a decrease in the number of elective procedures such as operations. Due to financial difficulties, patients may postpone nonurgent procedures, reducing demand for ACDs, revenue is expected to decrease by 41% in 2022.
Resources may be limited in hospitals and healthcare facilities, limiting their capacity to perform artificial cervical disc procedures. Research and development efforts in ACD may be reduced due to financial constraints. Consumer confidence, health spending and investment in medical innovation would have to be restored if the market was to recover from the recession. surgery. Patients may delay nonurgent procedures due to financial concerns, reducing demand for ACDs. The restoration of consumer confidence, healthcare spending and investments in health innovation would be essential for the market to recover from the recession.
By Type
Cervical artificial disc
Lumbar artificial disc
Cervical artificial disc segment will remain dominant the market during the forecast period. As an alternative to spine fusion, cervical disc replacement is extensively used for quicker recovery following surgery. The growing concerns associated with post-surgery risks of spinal fusion has accelerated the patient preference for cervical artificial disc replacement procedures. Compared to fusion, long lasting results, and low risk of recurrence at the same different cervical level, this type of disc replacement method offers less recovery time, better results than fusion, long lasting results, and low risk of recurrence at the same different cervical level. In addition, the demand for Artificial Discs will increase due to a rising incidence of cervicogenic headaches caused by problems in the upper neck.
By Material
Metal-on-metal
Metal-on-polymer
Others
The metal-on-metal material segment accounted for more than 36.3% share of the artificial disc market in 2023. As compared to metal-on-biopolymer, metal-on-metal devices are relatively cheaper, and thus record significant preference. Metal-based implants made up of cobalt-based alloys, stainless steel, and titanium-based alloys are extensively used to manufacture diverse orthopedic implants. These implants are cost-effective, durable, and feature excellent mechanical properties. The ongoing developments and studies conducted for the development of degradable metal-based implants will also augment the artificial disc industry.
By Indication
Spinal trauma
Degenerative spine disease
End-use
Hospitals
Specialty clinic
Others
Ambulatory surgical centers segment is projected to exhibit over 2.6% CAGR from 2024-2031. The growing number of artificial disc replacement procedures performed in ambulatory surgical centers (ASCs) can be credited to the presence of favorable reimbursement scenario. Additionally, ASCs offer convenient and affordable healthcare along with access to state-of-the-art medical equipment and implants, thus attracting a large patient pool. Moreover, the advent of outpatient spine surgery and the growing preference for minimally invasive spine treatment will boost the demand for artificial discs across these settings.
.png)
Need any customization research on Artificial Cervical Disc Market - Enquiry Now
Regional Analysis
The largest share market share of the artificial discs was held by North America. The economies of the United States and Canada, with a strong healthcare infrastructure as well as good numbers of medical facilities, are located in North America. The United States has over 6,000 hospitals registered, according to data from the American Hospital Association. The surging geriatric population, the rapid integration of advanced medical technologies and the rising disposable income will augment industry expansion across North America.
Asia Pacific is expected to have the highest growth over the forecast period, driven by rapid development of health care infrastructure and increased spending on healthcare, a high number of people and an increase in medical tourism in developed countries such as China, Japan or India.
REGIONAL COVERAGE:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Some of the major key players are as follows: Alphatec Spine, Braun Melsungen AG, AxioMed, Centinel Spine, LLC, Aditus Medical, Globus Medical Inc, Johnson & Johnson, Orthofix Company, Medtronic PLC, Nuvasive Inc., Simplify Medical, Zimmer Biomet Holdings Inc. and Other Players.
Recent Developments:
In September 2022, NuVasive, Inc. has introduced the Reline cervical fixation system for posterior cervical fusion.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 1.31 Billion |
| Market Size by 2031 | US$ 2.68 Billion |
| CAGR | CAGR of 9.4% From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2023 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product Type (Cervical Disc, Lumbar Disc) • By Material (Metal-on-metal, Metal-on-biopolymer) • By End User (Hospitals, Ambulatory Surgical Centers, Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Alphatec Spine, Braun Melsungen AG, AxioMed, Centinel Spine, LLC, Aditus Medical, Globus Medical Inc, Johnson & Johnson, Orthofix Company, Medtronic PLC, Nuvasive Inc., Simplify Medical, Zimmer Biomet Holdings Inc. |
| Key Drivers | • Increased incidence of degenerative spine diseases worldwide |
| RESTRAINTS | • High price of the item • Inconsistent Reimbursement Procedures |
Ans. The Artificial Cervical Disc market is expected to grow at a CAGR of 9.4% over the forecast period 2024-2031
Ans: The Artificial Cervical Disc Market size is estimated to reach US$ 2.68 billion by 2031
Ans. Artificial Cervical Disc Market is divided into four segments and they are By Product Type, By Material, and By End User
Ans. North America holding the highest share of the worldwide artificial disc market.
Ans. Cervical Disc and Lumbar Disc are sub segments of by product type of the Artificial Cervical Disc Market.
TABLE OF CONTENTS
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Industry Flowchart
3. Research Methodology
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
5. Impact Analysis
5.1 Impact of Russia-Ukraine Crisis
5.2 Impact of Economic Slowdown on Major Countries
5.2.1 Introduction
5.2.2 United States
5.2.3 Canada
5.2.4 Germany
5.2.5 France
5.2.6 UK
5.2.7 China
5.2.8 Japan
5.2.9 South Korea
5.2.10 India
6. Value Chain Analysis
7. Porter’s 5 Forces Model
8. Pest Analysis
9. Artificial Cervical Disc Market Segmentation, by Type
9.1 Introduction
9.2 Trend Analysis
9.3 Cervical artificial disc
9.4 Lumbar artificial disc
10. Artificial Cervical Disc Market Segmentation, by Material
10.1 Introduction
10.2 Trend Analysis
10.3 Metal-on-metal
10.4 Metal-on-polymer
10.5 Others
11. Artificial Cervical Disc Market Segmentation, by Indication
11.1 Introduction
11.2 Trend Analysis
11.3 Spinal trauma
11.4 Degenerative spine disease
12. Artificial Cervical Disc Market Segmentation, by End-use
12.1 Introduction
12.2 Trend Analysis
12.3 Hospitals
12.4 Specialty clinic
12.5 Ambulatory surgical centers
12.6 Others
13. Regional Analysis
13.1 Introduction
13.2 North America
13.2.1 USA
13.2.2 Canada
13.2.3 Mexico
13.3 Europe
13.3.1 Eastern Europe
13.3.1.1 Poland
13.3.1.2 Romania
13.3.1.3 Hungary
13.3.1.4 Turkey
13.3.1.5 Rest of Eastern Europe
13.3.2 Western Europe
13.3.2.1 Germany
13.3.2.2 France
13.3.2.3 UK
13.3.2.4 Italy
13.3.2.5 Spain
13.3.2.6 Netherlands
13.3.2.7 Switzerland
13.3.2.8 Austria
13.3.2.9 Rest of Western Europe
13.4 Asia-Pacific
13.4.1 China
13.4.2 India
13.4.3 Japan
13.4.4 South Korea
13.4.5 Vietnam
13.4.6 Singapore
13.4.7 Australia
13.4.8 Rest of Asia Pacific
13.5 The Middle East & Africa
13.5.1 Middle East
13.5.1.1 UAE
13.5.1.2 Egypt
13.5.1.3 Saudi Arabia
13.5.1.4 Qatar
13.5.1.5 Rest of the Middle East
13.5.2 Africa
13.5.2.1 Nigeria
13.5.2.2 South Africa
13.5.2.3 Rest of Africa
13.6 Latin America
13.6.1 Brazil
12.6.2 Argentina
13.6.3 Colombia
13.6.4 Rest of Latin America
14. Company Profiles
14.1 Alphatec Spine
14.1.1 Company Overview
14.1.2 Financial
14.1.3 Products/ Services Offered
14.1.4 SWOT Analysis
14.1.5 The SNS View
14.2 Braun Melsungen AG
14.2.1 Company Overview
14.2.2 Financial
14.2.3 Products/ Services Offered
14.2.4 SWOT Analysis
14.2.5 The SNS View
14.3 AxioMed
14.3.1 Company Overview
14.3.2 Financial
14.3.3 Products/ Services Offered
14.3.4 SWOT Analysis
14.3.5 The SNS View
14.4 Centinel Spine, LLC
14.4.1 Company Overview
14.4.2 Financial
14.4.3 Products/ Services Offered
14.4.4 SWOT Analysis
14.4.5 The SNS View
14.5 Aditus Medical
14.5.1 Company Overview
14.5.2 Financial
14.5.3 Products/ Services Offered
14.5.4 SWOT Analysis
14.5.5 The SNS View
14.6 Globus Medical Inc
14.6.1 Company Overview
14.6.2 Financial
14.6.3 Products/ Services Offered
14.6.4 SWOT Analysis
14.6.5 The SNS View
14.7 Johnson & Johnson
14.7.1 Company Overview
14.7.2 Financial
14.7.3 Products/ Services Offered
14.7.4 SWOT Analysis
14.7.5 The SNS View
14.8 Orthofix Company
14.8.1 Company Overview
14.8.2 Financial
14.8.3 Products/ Services Offered
14.8.4 SWOT Analysis
14.8.5 The SNS View
14.9 Medtronic PLC
14.9.1 Company Overview
14.9.2 Financial
14.9.3 Products/ Services Offered
14.9.4 SWOT Analysis
14.9.5 The SNS View
14.10 Nuvasive Inc.
14.10.1 Company Overview
14.10.2 Financial
14.10.3 Products/ Services Offered
14.10.4 SWOT Analysis
14.10.5 The SNS View
14.11 Simplify Medical
14.11.1 Company Overview
14.11.2 Financial
14.11.3 Products/ Services Offered
14.11.4 SWOT Analysis
14.11.5 The SNS View
14.12 Zimmer Biomet Holdings Inc.
14.12.1 Company Overview
14.12.2 Financial
14.12.3 Products/ Services Offered
14.12.4 SWOT Analysis
14.12.5 The SNS View
15. Competitive Landscape
15.1 Competitive Benchmarking
15.2 Market Share Analysis
15.3 Recent Developments
15.3.1 Industry News
15.3.2 Company News
15.3.3 Mergers & Acquisitions
16. Use Case and Best Practices
17. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Hypoparathyroidism Treatment Market Size was valued at USD 1.25 billion in 2023 and is expected to reach USD 2.25 billion by 2032 and grow at a CAGR of 6.8% over the forecast period 2024-2032.
The Recombinant Proteins Market size was USD 2.5 billion in 2023 and is expected to reach USD 5.0 billion by 2032 with a growing CAGR of 7.6% by 2023-2032.
The Blood Group Typing Market was estimated at USD 1.9 billion in 2023 and is poised to reach 4.05 billion in 2032 anticipated to expand at a compound annual growth rate of 8.8% for the forecast period of 2024-2032.
The ECG Equipment and Management Systems Market size at USD 6.9 billion in 2023, with a projected CAGR of 6.2% to reach USD 11.32 billion by 2031.
The Artificial Intelligence (AI) in Breast Imaging Market Size was USD 423.9 million in 2023 & will reach USD 1886.4 million by 2032 with a growing CAGR of 16.1% Over the Forecast Period of 2024-2032.
The Medical Document Management Systems Market Size was valued at USD 694.43 million in 2023 and is expected to reach USD 2102.78 million by 2032 and grow at a CAGR of 13.1% over the forecast period 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
